Article

Geneticist, retinal expert joins Jules Stein Eye Institute

Los Angeles-The Jules Stein Eye Institute (JSEI) and the Department of Ophthalmology of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), have appointed Michael Gorin, MD, the Harold and Pauline Price Chair in Ophthalmology and professor of ophthalmology in the retina and vision science divisions.

In his new post, Dr. Gorin will spend his time treating patients with retinal diseases, conducting genetic research on inherited eye disorders, and training young ophthalmologists. His primary focus is the molecular genetics of hereditary eye disorders, particularly age-related macular degeneration, retinitis pigmentosa, and Stargardt's disease.

The appointment represents a homecoming for Dr. Gorin, who completed his medical internship at the David Geffen School of Medicine before pursuing a postdoctoral fellowship and ophthalmology residency at JSEI.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.